Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. 1996

H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Republic of China.

OBJECTIVE Our purpose was to verify regional immune modulations and to test the effect of gonadotropin-releasing hormone agonist in women with endometriosis. METHODS Concentrations of peritoneal cytokines, including interleukin-1 beta, interleukin-2, soluble interleukin-2 receptor, interleukin-6, granulocyte-monocyte colony-stimulating factor, interferon gamma, and tumor necrosis factor-alpha were compared in women with and without endometriosis. Peritoneal cytokine and interleukin-2 production were examined by adding various mitogens to peritoneal fluid mononuclear cells of women with advanced endometriosis before and after gonadotropin-releasing hormone agonist treatment. RESULTS A significant increase in peritoneal interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha and a decrease in interferon gamma were noted in women with endometriosis. After gonadotropin-releasing hormone agonist treatment interleukin-6 decreased and interferon gamma increased. A significant impairment of interleukin-2 production of peritoneal fluid mononuclear cells by phytohemagglutinin and pokeweed mitogen stimulation was demonstrated in endometriosis, and production could be restored after gonadotropin-releasing hormone agonist treatment. CONCLUSIONS These results indicate that regional immunologic dysfunction might be invoked in the disease process of endometriosis.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016729 Leuprolide A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. Leuprorelin,A-43818,Enantone,Leuprolide Acetate,Leuprolide Monoacetate,Leuprolide, (DL-Leu)-Isomer,Leuprolide, (L-Leu)-Isomer,Lupron,TAP-144,A 43818,A43818,Acetate, Leuprolide,Monoacetate, Leuprolide,TAP 144,TAP144

Related Publications

H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
February 2009, Fertility and sterility,
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
June 1989, Journal of chemotherapy (Florence, Italy),
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
October 1994, American journal of reproductive immunology (New York, N.Y. : 1989),
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
January 1994, American journal of reproductive immunology (New York, N.Y. : 1989),
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
March 2002, Human reproduction (Oxford, England),
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
July 1981, Journal of clinical immunology,
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
August 2016, Journal of reproductive immunology,
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
April 1987, Transplantation proceedings,
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
August 1995, Ginekologia polska,
H N Ho, and M Y Wu, and K H Chao, and C D Chen, and S U Chen, and H F Chen, and Y S Yang
May 2001, Ginekologia polska,
Copied contents to your clipboard!